Skip to main content
. 2022 Feb 26;14(5):992. doi: 10.3390/nu14050992

Figure 2.

Figure 2

Changes in immune cell phenotypes in blood according to the intervention group (placebo vs. PMT25341). CD4, CD8, CD4/CD8 ratio, activation markers on CD4 and CD8 T cells, and exhaustion in CD4 T cells, at baseline and week 4 in HIV-infected children according to the intervention group (placebo vs. PMT25341).